New study launched to more accurately diagnose early hepatocellular carcinoma
A first of its kind cohort study on patients at high risk of developing primary liver cancer also known as hepatocellular carcinoma (HCC), has been launched to diagnose HCC more accurately at an earlier stage and to predict an individual s likelihood of developing the cancer. HCC is the sixth most common cancer in the world but the third most common cause of cancer deaths globally. In Singapore, HCC is the third and fourth most common cause of cancer deaths, amongst males and females respectively.
While potentially curative treatment is possible with early diagnosis, only 20% of HCC cases are detected at a stage where cure is possible. This investigator-initiated multi-centre study led by the National Cancer Centre of Singapore (NCCS) called EarLy DEtection of HCC: miRNA, microbiome and imaGing biomArkers in the evolution of chroNiC livEr Disease in a high-risk prospective cohort (ELEGANCE), addresses thi
„Fagfólk kemur aldrei í stað ástvina
mbl.is - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mbl.is Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Quantitative MR images of the liver from six patients presenting with liver cancer produced by Perspectum s LiverMultiScan which will be used in a new study led by National Cancer Centre. view more
Credit: Image credit: Mole DJ et al. Plos One. 2020;15(12):e0238568
Only 20% of primary liver cancer or hepatocellular carcinoma (HCC) are diagnosed at an early stage, which makes early detection an urgent, unmet healthcare need.
Study aims to develop more accurate diagnostics for early HCC, an AI algorithm to predict an individual s risk of developing HCC, and discover novel molecular targets to prevent the development of HCC.
Singapore turns to disco to keep Covid vaccine rollout on track Rebecca Ratcliffe South-east Asia correspondent
After vaccinating a fifth of its population, Singapore is deploying the powers of informative disco to keep up its inoculation campaign.
The city state was recently crowned the best place to be in the pandemic, and has managed to keep daily case numbers below 50 for months. But its latest public health video – an infectious pop song starring comedian Gurmit Singh as his much-loved character Phua Chu Kang, an eccentric contractor – warns the public not to be complacent.
“Low cases isn’t no cases,” he cries, after marching through a laboratory and vaccination centre in his trademark yellow boots, where he raps surprisingly detailed medical advice. “Singapore, don’t wait and see. Better get your shot Steady Pom Pi Pi [stay calm]”.
E-Mail
IMAGE: Quantitative MR images of the liver from six patients presenting with liver cancer produced by Perspectum s LiverMultiScan which will be used in a new study led by National Cancer Centre. view more
Credit: Mole DJ et al. Plos One. 2020;15(12):e0238568
Singapore, 3 May 2021 - A first of its kind cohort study on patients at high risk of developing primary liver cancer also known as hepatocellular carcinoma (HCC), has been launched to diagnose HCC more accurately at an earlier stage and to predict an individual s likelihood of developing the cancer. HCC is the sixth most common cancer in the world but the third most common cause of cancer deaths globally.[1] In Singapore, HCC is the third and fourth most common cause of cancer deaths, amongst males and females respectively.[2] While potentially curative treatment is possible with early diagnosis, only 20% of HCC cases are detected at a stage where cure is possible. This investigator-initiated multi-centre s
vimarsana © 2020. All Rights Reserved.